INTERSCOPE MED LTD - LONDON
| Company Profile | Company Filings |
Overview
INTERSCOPE MED LTD is a Private Limited Company from LONDON UNITED KINGDOM and has the status: Active.
INTERSCOPE MED LTD was incorporated 7 years ago on 18/01/2017 and has the registered number: 10569695. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
INTERSCOPE MED LTD was incorporated 7 years ago on 18/01/2017 and has the registered number: 10569695. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
INTERSCOPE MED LTD - LONDON
This company is listed in the following categories:
46180 - Agents specialized in the sale of other particular products
46180 - Agents specialized in the sale of other particular products
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
BIRCHIN COURT 5TH FLOOR
LONDON
EC3V 9DU
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 17/01/2024 | 31/01/2025 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| JEFFERY BENNITH RYAN | Jul 1979 | American | Director | 2017-01-18 | CURRENT |
| ZEDRA COSEC (UK) LIMITED | Corporate Secretary | 2017-01-18 | CURRENT |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| ACCOUNTS - Final Accounts preparation | 2023-07-21 | 31-12-2022 | 474 Cash -437,354 equity |
| ACCOUNTS - Final Accounts preparation | 2022-12-13 | 31-12-2021 | 4,660 Cash -330,425 equity |
| ACCOUNTS - Final Accounts preparation | 2021-09-29 | 31-12-2020 | 4,841 Cash -207,952 equity |
| ACCOUNTS - Final Accounts preparation | 2020-05-06 | 31-12-2019 | -55,895 equity |
| ACCOUNTS - Final Accounts preparation | 2019-02-07 | 31-12-2018 | -35,532 equity |
| ACCOUNTS - Final Accounts preparation | 2018-06-07 | 31-12-2017 | -9,671 equity |